US purchases Abbott, Celltrion rapid COVID-19 tests


Rapid COVID-19 tests made by Celltrion and Abbott Laboratories will be purchased by the US for use in nursing homes and high-risk populations, according to an unnamed senior administration official. The federal government agreed to pay more than $1 billion total for the tests from the two manufacturers.

Full story:

FDLI SmartBrief

The latest regulatory and company news on food, drugs, animal drugs, biologics, cosmetics, diagnostics, dietary supplements, medical devices and tobacco

Designed specifically for professionals involved in the food and drug law community, FDLI SmartBrief is a FREE daily e-mail newsletter. It provides the latest need-to-know news and industry information that maximizes your time, giving you an edge over your competition.